I went through a enormous amount of tests yesterday, My PSA has risen from 4.3 to 17.9 and new bone Mets have appeared , multiple new ones were visable on the ribs and eliac, I believe I am experiencing pain as a result. I am concerned this harpoon trial will not be effective, and further delay a treatment less experimental. It starts at OHSU for my two night stay the 21st. I am grateful for the opportunity although I hope it's the correct choice given my acceleration of Mets etc. Should I push for something like SBRT or a compliment to the lupron and zometa. Thxs my friends
Clinical trials coming soon! - Advanced Prostate...
Clinical trials coming soon!
Written by
Costarica1961
To view profiles and participate in discussions please or .
Read more about...
6 Replies
•
SBRT is likely useless. You can add Celebrex to the Zometa. In STAMPEDE, the combination increased survival by 22%. I don't think it will interfere with your clinical trial. email this to Dr Beer:
The information on the Harpoon website indicates promising initial results. The technology is sound. I believe you are fortunate to be in the program. Cheers, Phil
Hello Costa. I fly to Los Angeles in 1 week to meet with Dr Dorff regarding the similar Amgen 160 trial. From what I have heard, these BiTE trials are cutting edge cancer immunotherapy, so hopefully we’ll both have a favorable result. Can you tell me about the screening process that you had to go through?
Not what you're looking for?
You may also like...
Entering Clinical Trials
My recent biopsy shows no evidence of a new BRAC1/2 mutation so the PARB inhibitors are not an...
Treatment naïve and clinical trials
Treatment naïve and clinical trials....
I am asking this question for a friend. Does anyone here...
Blood transfusions dependent/clinical trials.
Hello, I have been blood transfusion dependent for the past year. I go on a weekly basis. My...
Clinical Trials
Hey you's guys, (that's a term that includes the ladies from when I was a kid)
Instead of reading a...
Cycle 1 of Clinical Trials
Yesterday was my first round of treatments for a new clinical trial that involves an infusion of a...